Huize Holding Ltd. Sponsored ADR Class A (HUIZ.US) H1 total premium was 3.05 billion yuan. In Q2, repurchasing customers accounted for 40.5% of long-term insurance.
Huize (HUIZ.US) released its financial report.
On September 25th, the leading domestic insurance e-commerce service platform Huize Holding Ltd. Sponsored ADR Class A (HUIZ.US) released its unaudited financial report for the second quarter of 2024 before the opening of the US stock market. The data showed that in the first half of the year, the total insurance premium facilitated by Huize Holding Ltd. Sponsored ADR Class A's platform reached 3.05 billion yuan, with total revenue reaching 590 million yuan. During Q2, the platform's cumulative insured users increased to 9.8 million, with 240,000 new insured users in the quarter. Based on this, the total first-year premium facilitated by the entire platform reached 650 million yuan, with long-term insurance business premiums accounting for 91.3%, consistently exceeding 90% for nineteen consecutive quarters, with repeat customers accounting for 40.5%, a year-on-year increase of 6.5 percentage points. In terms of the first-year premium calculation, the average savings insurance amount reached 78,000 yuan, a year-on-year increase of 22.7%. As of the end of June, the persistency rates for the 13th and 25th months of long-term insurance both exceeded 95%. The proportion of new single premiums for customized products increased by 16.9 percentage points year-on-year, reaching 41.2%.
Related Articles

TRAD CHI MED (00570) released its annual performance report, with a net loss of 458 million RMB, compared to a profit in the same period last year.

XXF(02473): Mai Baowen appointed as Company Secretary.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced its annual performance, with a net profit attributable to shareholders of 2.983 billion yuan, an increase of 5.21% year-on-year.
TRAD CHI MED (00570) released its annual performance report, with a net loss of 458 million RMB, compared to a profit in the same period last year.

XXF(02473): Mai Baowen appointed as Company Secretary.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced its annual performance, with a net profit attributable to shareholders of 2.983 billion yuan, an increase of 5.21% year-on-year.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


